Galtec

Private

Buenos AiresHealthcare & Life Scienceshttps://galtec.ar/

Last Round

Seed

Dec 15, 2023

Company Overview

Galtec is a biotechnology company that develops immunotherapies based on the modulation of galectins for the treatment of cancer, autoimmune diseases, and chronic inflammatory conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biotechnologyimmunotherapydrug discoverymonoclonal antibodiesglycobiologycancer therapyautoimmune disease treatmentbiotech startupgalectin-1glycocheckpointsbiopharmapreclinical developmenttherapeutic candidatespatent licensingdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Galtec Comps

Public and private peers based on sector, stage, and business model.

Galtec comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Galtec Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Dec 15, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Daniel Falcón

Co Founder and CEO

Founding Team

Galtec Investors

Notable investors and investment history

Galtec investors
Investor	Rounds
White Lions	Seed

View all Investors

Galtec Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Galtec Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Galtec's valuation, stock price, and market status.

Firmographic Details

HeadquartersBuenos Aires

Employee Range13

Year Founded2023

Last FundingDec 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.